Optimizing Combination Cancer Therapy Based on Single Cell Analysis
summary
Single-cell mass cytometry measuring ~40 markers per cell is ordered into a Spade minimum spanning tree that recovers developmental branches, then populations are auto-gated by a CAST decision-tree to produce homogeneous subpopulations (thousands of cells each). Intracellular perturbation responses are summarized by a Bayesian probability matrix and assembled into a nested effects model for drug combinations that scores minimal drug sets; validated on an ovarian (HeLa-derived) cell line with TRAIL plus three kinase inhibitors, predicted 2– and 3‑drug rankings match survival assays.
AI-written summary · about
chapters (17)
- 0:00Introduction to signaling
- 1:33Single-cell technologies
- 3:46Spade algorithm development
- 6:04Spade methodology
- 8:32Validation of Spade
- 10:16Inferences in cancer
- 11:24Other analysis algorithms
- 13:09Perturbation analysis
- 14:48Signaling map applications
- 16:35Clinical relevance
- 18:39Cast algorithm
- 20:04Improving signaling robustness
- 22:06Optimal drug combination
- 23:17Graphical models
- 25:51HeLa cell case study
- 26:57Data-driven results
- 29:58Conclusion and Q&A
